Stereotaxis Inc Share Price Other OTC
Equities
US85916J4094
Advanced Medical Equipment & Technology
Sales 2024 * | 30.88M 2.57B | Sales 2025 * | 44.25M 3.69B | Capitalization | 192M 16.02B |
---|---|---|---|---|---|
Net income 2024 * | -19M -1.58B | Net income 2025 * | -16M -1.33B | EV / Sales 2024 * | 6.22 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.34 x |
P/E ratio 2024 * |
-9.96
x | P/E ratio 2025 * |
-12.5
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.12% |
Latest transcript on Stereotaxis Inc
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 57 | 29/16/29 | |
Kimberly Peery
DFI | Director of Finance/CFO | 55 | 01/03/01 |
Laura Garth
LAW | General Counsel | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Messey
BRD | Director/Board Member | 78 | 01/05/01 |
Chief Executive Officer | 57 | 29/16/29 | |
Nathan Fischel
BRD | Director/Board Member | 68 | 03/17/03 |
1st Jan change | Capi. | |
---|---|---|
+7.84% | 218B | |
+7.35% | 183B | |
+13.04% | 134B | |
+26.03% | 106B | |
-1.33% | 61.12B | |
+4.81% | 50.89B | |
+0.30% | 40.3B | |
+2.78% | 35.53B | |
+26.14% | 32.05B |